首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >A fluorescence optosensor for analyzing naphazoline in pharmaceutical preparations. Comparison with other sensors.
【24h】

A fluorescence optosensor for analyzing naphazoline in pharmaceutical preparations. Comparison with other sensors.

机译:一种用于分析药物制剂中萘甲唑啉的荧光光电传感器。与其他传感器的比较。

获取原文
获取原文并翻译 | 示例
       

摘要

We have developed an optical sensor for determining and quantifying naphazoline (NPZ) based on its inherent fluorescence property. We have placed a non-ionic-exchanger solid support (Amberlite XAD-7) in a flow cell in the light path of the excitation beam and the fluorescence signal for NPZ is continuously monitored at lambda(excm)=294/306 nm. The response time for this sensor is acceptably fast, 80s, obtaining a detection limit of 2.6 ng mL(-1) with standard deviations of 2.0% at 125 ng mL(-1). This device has been satisfactorily applied to two commercial formulations and its selectivity has been demonstrated with an interference study. The advantages have been compared with the only published sensor for determining NPZ in pharmaceutical preparations and with other analytical methods in the literature.
机译:我们已经开发出一种光学传感器,用于根据其固有的荧光特性确定和定量萘甲唑啉(NPZ)。我们将非离子交换固体支持物(Amberlite XAD-7)放置在激发光束光路中的流通池中,并在λ(exc / nm)= 294/306 nm处连续监测NPZ的荧光信号。该传感器的响应时间为80秒,可以接受,非常快,可以达到2.6 ng mL(-1)的检出限,在125 ng mL(-1)时的标准偏差为2.0%。该装置已经令人满意地应用于两种商业配方,并且其选择性已经通过干扰研究得到证明。该优点已与唯一公开的用于确定药物制剂中NPZ的传感器以及文献中的其他分析方法进行了比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号